pubmed-article:12883677 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12883677 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:12883677 | lifeskim:mentions | umls-concept:C0597032 | lld:lifeskim |
pubmed-article:12883677 | lifeskim:mentions | umls-concept:C1518051 | lld:lifeskim |
pubmed-article:12883677 | lifeskim:mentions | umls-concept:C1527249 | lld:lifeskim |
pubmed-article:12883677 | lifeskim:mentions | umls-concept:C0034897 | lld:lifeskim |
pubmed-article:12883677 | lifeskim:mentions | umls-concept:C1446468 | lld:lifeskim |
pubmed-article:12883677 | lifeskim:mentions | umls-concept:C1521996 | lld:lifeskim |
pubmed-article:12883677 | lifeskim:mentions | umls-concept:C1707520 | lld:lifeskim |
pubmed-article:12883677 | lifeskim:mentions | umls-concept:C0205262 | lld:lifeskim |
pubmed-article:12883677 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:12883677 | pubmed:dateCreated | 2003-7-28 | lld:pubmed |
pubmed-article:12883677 | pubmed:abstractText | This study investigated whether it is possible to detect patients who have a high risk of metastasis and recurrence after resection of stage II Dukes' B primary colorectal cancer. Among 434 patients who underwent curative resection of primary colorectal cancer, 167 (38.5%) had Dukes' B cancer. Among them, 19 patients (11.4%) suffered from postoperative metastasis or recurrence. In 17 patients with recurrence who could be followed-up completely (recurrence group) and 17 other patients who survived for at least 5 years without recurrence (non-recurrence group), immunohistochemical staining of resected lymph nodes for cytokeratin (AE1/AE3 and CAM 5.2) was performed. AE1/AE3 was positive in 76.5% and 47.1% of the patients from the recurrence and non-recurrence groups, respectively, while CAM 5.2 was positive in 52.9% and 17.6%, respectively. There were no significant differences of either AE1/AE3 or CAM 5.2 positivity between the groups. However, the occult neoplastic cell count (mean +/- SD) floating in the lymph node sinuses was significantly higher in patients from the recurrence group who were positive for AE1/AE3 or CAM 5.2 than in patients from the non-recurrence group (6.12+/-6.00 vs. 0.59+/-0.71; p=0.0019 and 3.94+/-5.06 vs. 0.29+/-0.69; p=0.0098, respectively). These results suggest that patients with Dukes' B primary colorectal cancer who have a higher risk of recurrence can be selected by immunostaining of resected lymph nodes for cytokeratin. | lld:pubmed |
pubmed-article:12883677 | pubmed:language | eng | lld:pubmed |
pubmed-article:12883677 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12883677 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12883677 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12883677 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12883677 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12883677 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12883677 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12883677 | pubmed:issn | 1021-335X | lld:pubmed |
pubmed-article:12883677 | pubmed:author | pubmed-author:MukaiMasayaM | lld:pubmed |
pubmed-article:12883677 | pubmed:author | pubmed-author:MakuuchiHiroy... | lld:pubmed |
pubmed-article:12883677 | pubmed:author | pubmed-author:NishidaTomomi... | lld:pubmed |
pubmed-article:12883677 | pubmed:author | pubmed-author:KomatsuNobuka... | lld:pubmed |
pubmed-article:12883677 | pubmed:author | pubmed-author:KIDDA AAA | lld:pubmed |
pubmed-article:12883677 | pubmed:author | pubmed-author:NakasakiHisao... | lld:pubmed |
pubmed-article:12883677 | pubmed:author | pubmed-author:SatoShinkichi... | lld:pubmed |
pubmed-article:12883677 | pubmed:author | pubmed-author:ShibaKazuakiK | lld:pubmed |
pubmed-article:12883677 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12883677 | pubmed:volume | 10 | lld:pubmed |
pubmed-article:12883677 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12883677 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12883677 | pubmed:pagination | 1177-81 | lld:pubmed |
pubmed-article:12883677 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:12883677 | pubmed:meshHeading | pubmed-meshheading:12883677... | lld:pubmed |
pubmed-article:12883677 | pubmed:meshHeading | pubmed-meshheading:12883677... | lld:pubmed |
pubmed-article:12883677 | pubmed:meshHeading | pubmed-meshheading:12883677... | lld:pubmed |
pubmed-article:12883677 | pubmed:meshHeading | pubmed-meshheading:12883677... | lld:pubmed |
pubmed-article:12883677 | pubmed:meshHeading | pubmed-meshheading:12883677... | lld:pubmed |
pubmed-article:12883677 | pubmed:meshHeading | pubmed-meshheading:12883677... | lld:pubmed |
pubmed-article:12883677 | pubmed:meshHeading | pubmed-meshheading:12883677... | lld:pubmed |
pubmed-article:12883677 | pubmed:meshHeading | pubmed-meshheading:12883677... | lld:pubmed |
pubmed-article:12883677 | pubmed:meshHeading | pubmed-meshheading:12883677... | lld:pubmed |
pubmed-article:12883677 | pubmed:meshHeading | pubmed-meshheading:12883677... | lld:pubmed |
pubmed-article:12883677 | pubmed:meshHeading | pubmed-meshheading:12883677... | lld:pubmed |
pubmed-article:12883677 | pubmed:meshHeading | pubmed-meshheading:12883677... | lld:pubmed |
pubmed-article:12883677 | pubmed:articleTitle | Correlation between occult neoplastic cells in the lymph node sinuses and recurrence in patients with curatively resected Dukes' B colorectal cancer. | lld:pubmed |
pubmed-article:12883677 | pubmed:affiliation | Department of Surgery, Tokai University Oiso Hospital, Kanagawa 259-0198, Japan. colorectalmasaya@yahoo.co.jp | lld:pubmed |
pubmed-article:12883677 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12883677 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |